Satya Therapeutics Celebrates 1,000th Client Milestone, Industry Leadership, and New Initiatives

ASHLAND, OR / ACCESS Newswire / May 27, 2025 / Satya Therapeutics, Oregon's leading psilocybin service center and manufacturer, is proud to announce a major milestone: serving its 1,000th client since opening in July 2023. This achievement underscores Satya's commitment to accessible, safe, and transformative psilocybin services for people from all walks of life.

"Our 1,000th client marks not just a number, but a testament to our leadership and the trust our community places in us," said CEO Jennifer Met. "We are proud of the profound impact our work has had, helping people heal and grow." COO Andreas Met added, "We've built a strong team united by a vision: to make psilocybin services accessible, inclusive, and effective across Oregon."

Satya celebrates the dedication of its facilitators, whose expertise and compassion have been central to this milestone:

• Dr. Bonny Koeber - 165 clients - psilocybinjourneyguide.com

• Dabney Finney - 150 clients

• Andreas Met - 141 clients - enduringcactus.com

• Bern Haggard - 106 clients - cybinservice.com

• Meixa Marie Shore - 77 clients - meixamarie.com/psilocybinfacilitation

• Naoko Bishop - 67 clients - luminalifejourney.com

• Shelah Wind-Smith - 53 clients - ripplecare.com

• Shasta Winn - 50 clients - myco-method.com/psilocybin-sessions

• Nine Other Facilitators - 264 clients

Note: The total is higher than 1,000 clients due to some facilitators seeing clients at other service centers.

Satya's facilitators are among the most experienced in the nation, with four surpassing 100 client sessions-a benchmark rarely seen in this emerging industry. Satya's trauma-informed approach and innovative dosing strategies, especially for clients with complex needs or concurrent medications, set the standard for care and safety.

Satya also believes that clients choose Satya because the costs are reasonable. Clients can receive exceptional psilocybin therapy for $1,000 to $1,250, all-inclusive.

Manufacturing Re-Licensing and Industry Advocacy

Satya is currently undergoing its state manufacturing re-licensing process, with inspection expected in June. "2025 and 2026 will be pivotal for the psilocybin industry," said Andreas Met. "With many manufacturers exiting the market, Satya is committed to sustaining Oregon's supply with low-cost, high-quality psilocybin. Our goal is to build a 100,000 mg stockpile to ensure service centers can thrive despite industry headwinds. Satya sells psilocybin to other service centers for $1.00 per mg, far below the prices charged by other licensed manufacturers."

Expanding Education and Outreach

Recognizing the need for accessible information, Satya has launched a series of podcasts and YouTube videos to educate potential clients about psilocybin therapy, its benefits, and the client journey. "The average client spends 15 hours researching psilocybin therapy before visiting us," said Jennifer Met. "We aim to fill the information gap and empower more people to explore psilocybin services safely."

Policy Engagement and Industry Sustainability

Satya is actively engaging with Oregon state legislators to advocate for the Oregon Psilocybin Services program amid Oregon Health Authority budget challenges. With the threat of doubled licensing fees, Satya warns of further service center closures but remains committed to affordability. "Our mission is to keep services accessible, regardless of regulatory changes," Jennifer Met emphasized. "Word of mouth and client results will continue to drive our growth and the industry's future."

Participation in the Newly Formed Psilocybin Alliance

Satya is excited to join the newly formed Psilocybin Alliance (www.psilocybin-alliance.org), a collective of facilitators and operators dedicated to inclusivity, best practices, and industry guidance. "The ‘Operators' are the industry," said Andreas Met. "The Alliance provides a unified voice to support one another and shape the future of psilocybin services in Oregon through legislative outreach."

Client Trends and Industry Outlook

Satya reports rising client numbers in May (51 clients seen) and a strong 17% repeat rate (returning customers), reflecting high satisfaction and value. While summer is typically slower, Satya remains optimistic and committed to remaining Oregon's leading service center. Unfortunately, the psilocybin industry in Oregon appears to be suffering, as the following numbers demonstrate:

The industry is burdened with high costs, increasingly complex regulations, and high overhead. Satya believes this summer will be a make-or-break situation for many operators. Andreas Met opined, "We had a record month in May. But this is an incredibly complicated and challenging business to operate. We're so proud to be ‘in it' and leading the way. We always wish we had more clients, but are exceptionally happy to see the profound-life-changing experiences-as they happen."

National Landscape

With Colorado's psilocybin program ramping up slowly and limited national awareness, Satya continues to distinguish itself through experience, affordability, and a client-centered model. "A strong news cycle benefits everyone," said Andreas Met. "Oregon-and Satya-remain the destination for safe, expert-guided psilocybin services."

For more information about Satya Therapeutics and its services, visit www.satyatherapeutics.com.

Media Contact:
Andreas Met, COO
Satya Therapeutics
541-930-2478
andreas@satyatherapeutics.com

SOURCE: SATYA INC.